TMDX
TransMedics Group Inc
NASDAQ: TMDX · HEALTHCARE · MEDICAL DEVICES
$98.57
-2.66% today
Updated 2026-04-29
Market cap
$3.41B
P/E ratio
20.24
P/S ratio
5.62x
EPS (TTM)
$4.87
Dividend yield
—
52W range
$89 – $156
Volume
1.0M
TransMedics Group Inc (TMDX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.90M | $58.10M | $37.00M | $42.16M | $105.30M | $152.03M | $134.89M | $277.15M | $706.05M | $804.08M |
| Cash & equivalents | $9.01M | $9.84M | $11.94M | $20.24M | $20.09M | $24.58M | $25.58M | $201.18M | $394.81M | $336.65M |
| Current assets | $12.77M | $55.86M | $34.04M | $34.79M | $100.00M | $146.77M | $118.70M | $252.29M | $510.65M | $497.22M |
| Total liabilities | $6.10M | $19.32M | $205.72M | $46.98M | $50.65M | $48.13M | $67.04M | $89.77M | $568.85M | $575.47M |
| Current liabilities | $3.51M | $9.47M | $10.90M | $12.55M | $16.11M | $11.88M | $23.24M | $23.66M | $54.93M | $59.91M |
| Long-term debt | $1.11M | $8.41M | $6.85M | $33.67M | $34.15M | $34.66M | $35.20M | $58.70M | $506.20M | $509.31M |
| Shareholder equity | $-65.63M | $38.79M | $-168.72M | $-4.83M | $54.65M | $103.89M | $67.85M | $187.38M | $137.20M | $228.60M |
| Retained earnings | $-65.64M | $-291.36M | $-312.18M | $-335.94M | $-369.48M | $-398.23M | $-442.45M | $-478.68M | $-503.70M | $-468.24M |
| Accounts receivable | — | $1.38M | $925000.00 | $3.44M | $6.56M | $6.86M | $5.93M | $27.61M | $63.58M | $97.72M |
| Inventory | $797000.00 | $6.33M | $7.97M | $9.28M | $11.22M | $11.93M | $14.86M | $20.61M | $44.23M | $46.55M |
| Goodwill | — | — | — | — | — | — | — | $0.00 | $11.99M | $11.55M |